1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Hemostatic Closure Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-Invasive Hemostatic Closure Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-Invasive Hemostatic Closure Devices by Country/Region, 2018, 2022 & 2029
2.2 Non-Invasive Hemostatic Closure Devices Segment by Type
2.2.1 Closure Strips
2.2.2 Tissue Adhesive
2.2.3 Sutures
2.3 Non-Invasive Hemostatic Closure Devices Sales by Type
2.3.1 Global Non-Invasive Hemostatic Closure Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Non-Invasive Hemostatic Closure Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-Invasive Hemostatic Closure Devices Sale Price by Type (2018-2023)
2.4 Non-Invasive Hemostatic Closure Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgery Centers
2.5 Non-Invasive Hemostatic Closure Devices Sales by Application
2.5.1 Global Non-Invasive Hemostatic Closure Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Non-Invasive Hemostatic Closure Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-Invasive Hemostatic Closure Devices Sale Price by Application (2018-2023)
3 Global Non-Invasive Hemostatic Closure Devices by Company
3.1 Global Non-Invasive Hemostatic Closure Devices Breakdown Data by Company
3.1.1 Global Non-Invasive Hemostatic Closure Devices Annual Sales by Company (2018-2023)
3.1.2 Global Non-Invasive Hemostatic Closure Devices Sales Market Share by Company (2018-2023)
3.2 Global Non-Invasive Hemostatic Closure Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Non-Invasive Hemostatic Closure Devices Revenue by Company (2018-2023)
3.2.2 Global Non-Invasive Hemostatic Closure Devices Revenue Market Share by Company (2018-2023)
3.3 Global Non-Invasive Hemostatic Closure Devices Sale Price by Company
3.4 Key Manufacturers Non-Invasive Hemostatic Closure Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Invasive Hemostatic Closure Devices Product Location Distribution
3.4.2 Players Non-Invasive Hemostatic Closure Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Invasive Hemostatic Closure Devices by Geographic Region
4.1 World Historic Non-Invasive Hemostatic Closure Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-Invasive Hemostatic Closure Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-Invasive Hemostatic Closure Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-Invasive Hemostatic Closure Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Non-Invasive Hemostatic Closure Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-Invasive Hemostatic Closure Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-Invasive Hemostatic Closure Devices Sales Growth
4.4 APAC Non-Invasive Hemostatic Closure Devices Sales Growth
4.5 Europe Non-Invasive Hemostatic Closure Devices Sales Growth
4.6 Middle East & Africa Non-Invasive Hemostatic Closure Devices Sales Growth
5 Americas
5.1 Americas Non-Invasive Hemostatic Closure Devices Sales by Country
5.1.1 Americas Non-Invasive Hemostatic Closure Devices Sales by Country (2018-2023)
5.1.2 Americas Non-Invasive Hemostatic Closure Devices Revenue by Country (2018-2023)
5.2 Americas Non-Invasive Hemostatic Closure Devices Sales by Type
5.3 Americas Non-Invasive Hemostatic Closure Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Hemostatic Closure Devices Sales by Region
6.1.1 APAC Non-Invasive Hemostatic Closure Devices Sales by Region (2018-2023)
6.1.2 APAC Non-Invasive Hemostatic Closure Devices Revenue by Region (2018-2023)
6.2 APAC Non-Invasive Hemostatic Closure Devices Sales by Type
6.3 APAC Non-Invasive Hemostatic Closure Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Invasive Hemostatic Closure Devices by Country
7.1.1 Europe Non-Invasive Hemostatic Closure Devices Sales by Country (2018-2023)
7.1.2 Europe Non-Invasive Hemostatic Closure Devices Revenue by Country (2018-2023)
7.2 Europe Non-Invasive Hemostatic Closure Devices Sales by Type
7.3 Europe Non-Invasive Hemostatic Closure Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Hemostatic Closure Devices by Country
8.1.1 Middle East & Africa Non-Invasive Hemostatic Closure Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-Invasive Hemostatic Closure Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-Invasive Hemostatic Closure Devices Sales by Type
8.3 Middle East & Africa Non-Invasive Hemostatic Closure Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Invasive Hemostatic Closure Devices
10.3 Manufacturing Process Analysis of Non-Invasive Hemostatic Closure Devices
10.4 Industry Chain Structure of Non-Invasive Hemostatic Closure Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Invasive Hemostatic Closure Devices Distributors
11.3 Non-Invasive Hemostatic Closure Devices Customer
12 World Forecast Review for Non-Invasive Hemostatic Closure Devices by Geographic Region
12.1 Global Non-Invasive Hemostatic Closure Devices Market Size Forecast by Region
12.1.1 Global Non-Invasive Hemostatic Closure Devices Forecast by Region (2024-2029)
12.1.2 Global Non-Invasive Hemostatic Closure Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Invasive Hemostatic Closure Devices Forecast by Type
12.7 Global Non-Invasive Hemostatic Closure Devices Forecast by Application
13 Key Players Analysis
13.1 Medline
13.1.1 Medline Company Information
13.1.2 Medline Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.1.3 Medline Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medline Main Business Overview
13.1.5 Medline Latest Developments
13.2 3M Healthcare
13.2.1 3M Healthcare Company Information
13.2.2 3M Healthcare Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.2.3 3M Healthcare Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 3M Healthcare Main Business Overview
13.2.5 3M Healthcare Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.3.3 Medtronic Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Ethicon (Johnson & Johnson)
13.4.1 Ethicon (Johnson & Johnson) Company Information
13.4.2 Ethicon (Johnson & Johnson) Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.4.3 Ethicon (Johnson & Johnson) Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ethicon (Johnson & Johnson) Main Business Overview
13.4.5 Ethicon (Johnson & Johnson) Latest Developments
13.5 Biotronik
13.5.1 Biotronik Company Information
13.5.2 Biotronik Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.5.3 Biotronik Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biotronik Main Business Overview
13.5.5 Biotronik Latest Developments
13.6 Starch Medical
13.6.1 Starch Medical Company Information
13.6.2 Starch Medical Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.6.3 Starch Medical Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Starch Medical Main Business Overview
13.6.5 Starch Medical Latest Developments
13.7 Olympus
13.7.1 Olympus Company Information
13.7.2 Olympus Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.7.3 Olympus Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Olympus Main Business Overview
13.7.5 Olympus Latest Developments
13.8 Teleflex
13.8.1 Teleflex Company Information
13.8.2 Teleflex Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.8.3 Teleflex Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teleflex Main Business Overview
13.8.5 Teleflex Latest Developments
13.9 BSN medical
13.9.1 BSN medical Company Information
13.9.2 BSN medical Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.9.3 BSN medical Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BSN medical Main Business Overview
13.9.5 BSN medical Latest Developments
13.10 Baxter International
13.10.1 Baxter International Company Information
13.10.2 Baxter International Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.10.3 Baxter International Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Baxter International Main Business Overview
13.10.5 Baxter International Latest Developments
13.11 Radi Medical Systems
13.11.1 Radi Medical Systems Company Information
13.11.2 Radi Medical Systems Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.11.3 Radi Medical Systems Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Radi Medical Systems Main Business Overview
13.11.5 Radi Medical Systems Latest Developments
13.12 Abbott Vascular
13.12.1 Abbott Vascular Company Information
13.12.2 Abbott Vascular Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.12.3 Abbott Vascular Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Abbott Vascular Main Business Overview
13.12.5 Abbott Vascular Latest Developments
13.13 NeatStitch
13.13.1 NeatStitch Company Information
13.13.2 NeatStitch Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.13.3 NeatStitch Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 NeatStitch Main Business Overview
13.13.5 NeatStitch Latest Developments
13.14 Derma Sciences
13.14.1 Derma Sciences Company Information
13.14.2 Derma Sciences Non-Invasive Hemostatic Closure Devices Product Portfolios and Specifications
13.14.3 Derma Sciences Non-Invasive Hemostatic Closure Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Derma Sciences Main Business Overview
13.14.5 Derma Sciences Latest Developments
14 Research Findings and Conclusion
| ※参考情報 非侵襲性止血閉鎖装置は、主に外科手術や医療処置において出血を制御・止血するために使用されるデバイスです。これらの装置は、体に侵入せずに出血箇所を閉じることができるため、患者に対する負担が低く、回復時間を短縮することが可能です。近年、医療技術の進歩により、非侵襲的な方法での止血が注目されています。 この装置の定義は、出血を伴うトラウマや手術後の出血を迅速かつ効果的に制御する技術であり、基本的には皮下組織や血管に直接影響を与えずに止血を実現します。これによって、従来の外科的手法と比較して、合併症のリスクを軽減し、術後の回復を促進することが期待されます。 非侵襲性止血閉鎖装置の特徴の一つには、迅速な施用が挙げられます。特に緊急時には、迅速かつ効率的な止血が求められます。デバイスは、患者の負担を最小限に抑えつつ、必要な止血効果を提供します。また、患者の生理的反応に合わせて調整可能なデザインが多く、特に高齢者や小児、血液凝固障害のある患者など、特別な配慮が必要なケースにも対応できます。 種類としては、さまざまなタイプの非侵襲性止血閉鎖装置があります。例えば、圧迫バンド、クリップ、機械的止血装置などがあり、それぞれ異なるメカニズムで止血を実現します。圧迫バンドは、特定の部位に圧力を加えることにより、出血を防ぎます。クリップは、血管を物理的に閉じることによって止血を行います。これらの装置は、外科手術時や、外傷による出血管理において非常に有効です。 用途も多岐にわたります。例えば、外科手術や創傷処理、出血のトリアージが必要な緊急医療などで使用されます。また、家庭や救急現場における止血管理のツールとしても活躍しています。特に、一般市民が簡単に使える非侵襲性止血デバイスが開発されることで、災害時や事故時の初期対応において効果を発揮します。 関連技術についても触れると、非侵襲性止血は、さまざまな医療技術と相互に関連しています。例えば、超音波技術を用いた弾性圧迫装置が研究されており、これにより出血部位を正確に特定し、効果的な圧迫を行うことが可能になります。また、バイオマテリアルの進歩により、新たな止血材が開発され、非侵襲性デバイスと組み合わせて使用されるケースが増えています。これにより、止血効率がさらに向上しています。 さらに、医療現場における統合的アプローチも重要です。非侵襲性止血装置は、医療チームが出血制御のために一丸となって取り組む際に役立ちます。生理学的な知見や手術経験と、最新の技術を組み合わせることで、より安全な医療提供が実現できます。 今後の展望として、非侵襲性止血閉鎖装置の技術革新が進むことで、より多くの患者に対して安全で効果的な止血管理が提供できるようになることが期待されています。また、十分な臨床データを蓄積し、その有効性を証明することで、さらなる普及が進むでしょう。これにより、医療現場だけでなく、一般市民の生活の中でも止血管理の重要性が高まると考えられます。 非侵襲性止血閉鎖装置の研究や開発は、医療業界における重要な課題の一つとされており、多くの研究機関や企業が新しい技術の開発に力を入れています。これにより、今後さらに進化した装置が登場することが予想され、出血管理の新しいスタンダードを築くことにつながるでしょう。 最後に、非侵襲性止血閉鎖装置は、医療の現場に革命をもたらす可能性を秘めた重要な技術であり、今後の発展が非常に楽しみです。医療の進歩に伴い、より安全で効率的な方法で出血を管理する手段が提供されることで、多くの患者が恩恵を受けることが期待されます。医療従事者と患者双方にとって、有益な未来が広がっていくことを願っています。 |
